| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 9e-07 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |